FR8350M - - Google Patents

Info

Publication number
FR8350M
FR8350M FR157611A FR157611A FR8350M FR 8350 M FR8350 M FR 8350M FR 157611 A FR157611 A FR 157611A FR 157611 A FR157611 A FR 157611A FR 8350 M FR8350 M FR 8350M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR157611A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR8350M publication Critical patent/FR8350M/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0081Reaction with amino acids, peptides, or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR157611A 1967-07-03 1968-10-01 Expired FR8350M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65062167A 1967-07-03 1967-07-03

Publications (1)

Publication Number Publication Date
FR8350M true FR8350M (fr) 1970-12-28

Family

ID=24609625

Family Applications (1)

Application Number Title Priority Date Filing Date
FR157611A Expired FR8350M (fr) 1967-07-03 1968-10-01

Country Status (5)

Country Link
US (1) US3506642A (fr)
BR (1) BR6800122D0 (fr)
DE (1) DE1768806C3 (fr)
FR (1) FR8350M (fr)
GB (1) GB1212055A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835112A (en) * 1970-06-08 1974-09-10 Etude Et D Exploit De Marques Heparin esters
CA1042001A (fr) * 1973-04-13 1978-11-07 Choay S.A. Sels d'heparine
US4024237A (en) * 1975-08-04 1977-05-17 Bertram Eichel Novel compositions for establishing environmental conditions favorable to oral leucocytes
HU172937B (hu) * 1975-12-18 1979-01-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh khondroitin-sernoj kisloty s mestno anestezirujuhhim ehffektom
IT1075117B (it) * 1977-02-14 1985-04-22 Fedeli Gianfranco Complesso polisaccaridico arterioso,processo per la sua preparazione e suo impiego in terapia umana
SE425372B (sv) * 1977-07-18 1982-09-27 Ird Biomaterial Ab Sett att heparinisera en elektriskt laddad yta pa en medecinsk artikel avsedd att komma i kontakt med blod och medel for utforande av settet
USRE35770E (en) * 1978-11-06 1998-04-14 Choay, S.A. Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
US4826827A (en) * 1979-10-05 1989-05-02 Choay S.A. Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482603A1 (fr) * 1980-05-14 1981-11-20 Pharmindustrie Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
US4820811A (en) * 1982-04-21 1989-04-11 Research Corporation Amine reacted therapeutic agents
US4703042A (en) * 1984-05-21 1987-10-27 Bodor Nicholas S Orally active heparin salts containing multivalent cationic units
DE3422407A1 (de) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen Verwendung von heparinderivaten zur selektiven extrakorporalen praezipitation von low-density-lipoproteinen aus vollserum oder plasma
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
IT1242604B (it) * 1990-11-13 1994-05-16 Alfa Wassermann Spa Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US9169331B2 (en) * 2012-12-21 2015-10-27 Dionex Corporation Separation of glycans by mixed-mode liquid chromatography
CN109575156B (zh) * 2018-11-05 2021-02-23 上海宝维医药技术有限公司 一种低分子肝素的纯化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786050A (en) * 1954-04-20 1957-03-19 Erba Carlo Spa Process for the preparation of a heparin
US2884358A (en) * 1957-04-22 1959-04-28 Southern California Gland Co Process for preparing crude heparin
US2989438A (en) * 1958-12-29 1961-06-20 Roussel Uclaf Process of purifying heparin, and product produced therefrom
US3174903A (en) * 1961-09-14 1965-03-23 Szabo Hnos Kessler & Cia S R L Preparation of heparinoids
FR2576M (fr) * 1962-07-27 1964-06-08 Roussel Uclaf Nouveau médicament notamment pour le traitement des troubles de la coagulabilité sanguine.

Also Published As

Publication number Publication date
US3506642A (en) 1970-04-14
DE1768806C3 (de) 1976-01-02
DE1768806B2 (de) 1975-05-15
DE1768806A1 (de) 1972-03-23
GB1212055A (en) 1970-11-11
BR6800122D0 (pt) 1973-02-22

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
FR8350M (fr)
AT298283B (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
AU2256867A (fr)
AU2116667A (fr)
AU2528767A (fr)
AU3189468A (fr)
AU3151267A (fr)
AU2977667A (fr)
AU1273466A (fr)
AU610966A (fr)
AU2454867A (fr)
BE692375A (fr)
BE162295A (fr)
BE692374A (fr)
AU1614766A (fr)
AU3054676A (fr)
AU1677166A (fr)
AU1763766A (fr)
BE711068A (fr)
AU1868267A (fr)
BE710577A (fr)